Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Assessing the Impact of Neurology Morning Report on Neurophobia among Preclinical Medical Students
Research Methodology, Education, and History
Research Methodology and Education Posters (7:00 AM-5:00 PM)
002

Neurophobia reportedly limits career interest in neurology. Preclinical student attendance at MR provides early exposure to clinical neuroscience, potentially mitigating neurophobia and promoting career interest in neurology.

To assess whether attending neurology morning report (MR) reduces neurophobia and increases neurology career interest among preclinical medical students.

Preclinical medical students attended MR voluntarily during their second-year medical school neuroscience course. They completed pre-session and post-session anonymous surveys, which explored their specialties of interest, perceptions about neurology, and reflections on MR.

 

Thirty-five students participated over the past two years. Before attending MR, two students ranked neurology as their top specialty of interest and eight reported being “very interested” or “moderately interested” in pursuing neurology. After attending MR, four students ranked neurology as their top specialty of interest and nine reported significant interest.  Students were most surprised by the ease with which cases were discussed, the breadth of available treatment options for neurologic disorders, and the camaraderie between attendings and trainees. However, students felt an occasional superficiality in case discussions. Interestingly, no students found neurology to be less challenging after MR (three found it “more challenging” and nine found “no change”).  All either strongly or somewhat agreed that MR was “an effective way of integrating the preclinical course material with clinical practice,” and would attend another session.

Students appreciated incorporating clinical exposure to neurology during their preclinical years. Attending MR successfully increased exposure and interest towards a career in neurology. This study is limited by small sample size and a high proportion of participants with a previous interest in neuroscience. Further analysis of longitudinal data, including match results, will assist in quantifying the effect of MR on reducing neurophobia among preclinical medical students. 

Authors/Disclosures
Sarah C. Parauda, MD (Westchester Medical Center)
PRESENTER
Dr. Parauda has nothing to disclose.
No disclosure on file
Ryka Sehgal, MD (UCSF) Ms. Sehgal has nothing to disclose.
Alice Tao Ms. Tao has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Julia I. Klein Ms. Klein has nothing to disclose.
Carrie Sha Ms. Sha has nothing to disclose.
Stefano Sandrone, PhD Dr. Sandrone has nothing to disclose.
Matthew S. Robbins, MD, FAAN (Weill Cornell Medicine) Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, American Academy of Neurology that is relevant to AAN interests or activities.
Joseph E. Safdieh, MD, FAAN (Weill Medical College of Cornell University) Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Harini Sarva, MD, FAAN (Weill Cornell Medical Center) Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB.